Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson's disease. - Wikidata - awgldk - TriplyDB

Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson's disease.

Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson's disease.

http://www.wikidata.org/entity/Q33696818

about

Psychological Benefits of Nonpharmacological Methods Aimed for Improving Balance in Parkinson's Disease: A Systematic Review Melatoninergic System in Parkinson's Disease: From Neuroprotection to the Management of Motor and Nonmotor Symptoms Depression, anxiety, and apathy in Parkinson's disease: insights from neuroimaging studies Social phobia in Parkinson's disease: Prevalence and risk factors Parkinson's disease as a disconnection syndrome Parkinson's disease: the quintessential neuropsychiatric disorder Systematic review of factors associated with depression and anxiety disorders among older adults with Parkinson's disease.Psychiatric aspects of Parkinson's disease.Specifying child anxiety disorders not otherwise specified in the DSM-IV.Anxiety and self-perceived health status in Parkinson's disease Neurobiology of depression and anxiety in Parkinson's disease Impact of anxiety on quality of life in Parkinson's disease.Neurocognitive correlates of apathy and anxiety in Parkinson's disease.The Effect of SSRIs on the Binding of (18)F-FP-CIT in Parkinson Patients: A Retrospective Case Control Study.Interventional magnetic resonance imaging-guided subthalamic nucleus deep brain stimulation for Parkinson's disease: Patient selection.Evaluation and management of the non-motor features of Parkinson's disease.The Therapeutic Potential of Exercise to Improve Mood, Cognition, and Sleep in Parkinson's Disease Familial aggregation of panic disturbances in Parkinson's disease Molecular imaging of neuropsychiatric symptoms in Alzheimer's and Parkinson's disease.Pharmacologic treatment of anxiety disorders in Parkinson disease.A latent class analysis of psychological disturbance in Parkinson's disease.REM sleep deprivation promotes a dopaminergic influence in the striatal MT2 anxiolytic-like effects Neuropsychiatric symptoms in untreated Parkinson's disease.Potential mechanisms underlying anxiety and depression in Parkinson's disease: consequences of l-DOPA treatment.Anxiety disorders: differential diagnosis and their relationship to chronic pain.The clinical spectrum of anxiety in Parkinson's disease.Management of anxiety and motor symptoms in Parkinson's disease.Parkinson's Disease and Driving Cessation: a Journey Influenced by Anxiety.Psychiatric Conditions in Parkinson Disease: A Comparison With Classical Psychiatric Disorders.A meta-analysis of third wave mindfulness-based cognitive behavioral therapies for older people.Emotional manifestations of PD: Neurobiological basis.Prevalence of anxiety in Parkinson's disease: A systematic review and meta-analysis.Clinical Presentation of Anxiety in Parkinson's Disease: A Scoping Review.Motion and emotion: anxiety-axial connections in Parkinson's disease.Prevalence, Patterns and Predictors of Psychotropic Polypharmacy Among Elderly Individuals with Parkinson's Disease In Long Term Care Settings In The United States.Modeling anxiety in Parkinson's disease.Dance for PD: a preliminary investigation of effects on motor function and quality of life among persons with Parkinson's disease (PD).Freezing of Gait and its Associations in the Early and Advanced Clinical Motor Stages of Parkinson's Disease: A Cross-Sectional Study.Excessive Sensitivity to Uncertain Visual Input in L-DOPA-Induced Dyskinesias in Parkinson's Disease: Further Implications for Cerebellar Involvement.Drug-induced burning mouth syndrome: a new clinico-pathological entity?

P2860

Q26800109-BBF65ED1-E729-42B2-BF09-B3A984468BC2 Q28075345-04453E8C-1E70-43B2-A891-31AF193F2442 Q28076779-E319B5E3-CD57-41AC-AC7A-ED5C992CDFE7 Q33726380-BED9D9B5-A262-409E-A69F-023E7E5B5281 Q33901047-51E4C33A-1801-4A98-9055-3E623F10C635 Q33917094-4FE45ABC-3A0B-4E26-8325-59C2CB452886 Q34417896-E03AEFAE-47DF-4E92-83E2-3844055AD3C3 Q34574771-ED3361D5-6755-48A2-9B4F-BBBA1CA10815 Q34647185-898FC03D-04EF-45EB-A673-092D260BCA19 Q34843179-05707C79-49BD-43C2-806A-9401EA588F3D Q35028706-39348B27-C7A9-4AB0-B999-6155311A6B8C Q35609023-F46B0B8F-0A2E-4DE8-8ABC-0EB78746118D Q35615127-8D3B1A2F-9352-4768-872B-75A614842AD5 Q36064565-5D89926F-00EB-45E1-9341-814C2DAA3306 Q36119433-E3521B65-499F-4191-8726-28750F95DE21 Q36443721-D522424D-AA55-433D-A67B-813995A4C895 Q36494212-03627755-5117-472E-AB56-E11D8E04969A Q36541534-6F4E13DC-163F-4F97-8927-DB022D5C4402 Q36724965-A8143FE7-00D5-4F6C-9A64-B2218108262C Q36847313-80D88F61-0924-4005-B3A8-CEF7CAAEF3A0 Q36849956-7F058FB3-E46A-4347-8094-2A1CE1A01A78 Q36903829-869208E3-E537-4D67-91C4-B8EF2F960CDA Q37714081-111D8572-4F2E-47F0-BA1E-C1E3BC5E4133 Q37771075-BEB3E5B0-8039-4DA9-8E0B-25002A1CE9B2 Q37924809-2AE4E387-73CA-452E-9B12-C591188C7656 Q38231914-D33930A3-416E-4BFC-86CE-85CAB725EF4A Q38233285-29202D7F-6B93-4FCD-BCD0-A1EDF5C58C66 Q38557746-0BAD2178-FD0A-4012-8C6F-546BB2B5D79A Q38588201-0506CA2E-D7D2-4132-A502-585EA26B0335 Q38793704-7ED784E8-97FE-4EB7-9A58-E3A24187A918 Q38797335-1C04DFC9-037B-4CDE-AB7F-F62D43BE0A89 Q38820278-28EBB249-E313-472B-9492-C50B77AB0766 Q38952143-21DC208D-FF12-470A-BB29-728FD58EA00E Q39160382-7D9636FB-3EB0-4758-8426-475CA3D7D9D2 Q40118089-9C92BF8A-6248-4CF7-AC0D-BE44F70EE863 Q40190713-C9C09088-A3A1-4860-B06B-5FD6B14F1CDD Q41120927-BA5DB153-5750-420D-BE41-62001CEDD824 Q41253920-BB48AAE3-BF7B-4183-9C1C-36166C2C6939 Q41910371-F2CE234C-A133-492F-A077-59D2058D71E0 Q42392289-A50A5BB5-8152-4CDD-A2E5-4354DF208A2B

P2860

Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson's disease.

http://www.wikidata.org/entity/Q33696818

description

2009 nî lūn-bûn

@nan

2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Prevalence of anxiety disorder ...... ents with Parkinson's disease.

@ast

Prevalence of anxiety disorder ...... ents with Parkinson's disease.

@en

type

label

Prevalence of anxiety disorder ...... ents with Parkinson's disease.

@ast

Prevalence of anxiety disorder ...... ents with Parkinson's disease.

@en

prefLabel

Prevalence of anxiety disorder ...... ents with Parkinson's disease.

@ast

Prevalence of anxiety disorder ...... ents with Parkinson's disease.

@en

P1433

Q33696818-839FAF2C-985D-45F7-8D56-917835F90598

P1476

Q33696818-1D1861A1-15C1-4590-9D62-2E506C722BEA

P2093

Q33696818-16211775-BB0E-4A7F-8E09-D669DFE3DC88

Q33696818-48165298-C42B-462B-9A68-E5FCC58D3252

Q33696818-5061C9FE-B5A1-4BAA-B030-5AB598BCBAF5

Q33696818-529C71BC-355F-472E-8ABB-3F826541B5A8

Q33696818-5B711F43-611E-40A7-90FE-FDFD3420BE5B

Q33696818-6728219C-F5FB-4B09-A69A-E862A3EC8C00

Q33696818-7F074200-310B-4990-8DAF-D9D89B69B689

Q33696818-80F4D5FA-95BB-48A2-AFF8-2E85B85CDC3B

Q33696818-BB94D7A2-E53A-4E97-9FD0-D0ACA6EB2F55

Q33696818-BE241EB5-E5DB-49E7-879C-2BA5AC62CA4A

P2860

Q33696818-08C16E2B-EBA1-4D2B-A0F3-E6A4D22CD4D6

Q33696818-15DF7275-7ECC-4521-AABE-A22F685C66CF

Q33696818-160A9475-FD70-4330-AC55-534A6248C509

Q33696818-24D6998A-2A53-4DFB-9BA2-C80E41A14E18

Q33696818-263AC025-33EC-405F-8966-D1893AD26A89

Q33696818-306F294F-200D-4834-956A-44B2D91B5DE8

Q33696818-42F3F96D-33C0-41BB-8A1F-5A53D52D3879

Q33696818-4AA9F516-2272-4FDB-A821-22A98A63E46D

Q33696818-4E1704EC-12AD-4A61-A78F-4B57ED30CE26

Q33696818-5AFB2051-0FED-4F5E-B01C-2EAB1208DC12

P304

Q33696818-A305B62F-E8E3-4F86-854A-D3F3DBB1AB66

P31

Q33696818-B99CF7B2-03AF-4A30-920A-D2057C07512E

P356

Q33696818-2D69EE5C-01DD-4198-9A24-DF3AADCB52D1

P407

Q33696818-81E867BB-F91F-4BF0-815E-28AF00C41A53

P433

Q33696818-0243E824-57E9-4007-A71E-8834EBFFED74

P478

Q33696818-D1AE4D17-D4EA-4583-80F0-FB69F08AFFF8

P577

Q33696818-4B0EB00E-9A37-4CF4-B0F7-FF6531A0169A

P5875

Q33696818-AD9A54B0-F478-45DD-8A06-C607502CA488

P698

Q33696818-DEEED308-92FE-4F98-A9E9-A902B0E9A9F9

P921

Q33696818-2CBDF662-6A0A-4E0E-B504-C9F2C6D73719

P932

Q33696818-3D8286CC-C6B7-4D7C-82CE-03D17C34D1D1

P356

P1433

Movement Disorders

P1476

Prevalence of anxiety disorder ...... ents with Parkinson's disease.

@en

P2093

Elaina S Hirsch

http://www.w3.org/2001/XMLSchema#string

Gary Chase

http://www.w3.org/2001/XMLSchema#string

Gregory M Pontone

http://www.w3.org/2001/XMLSchema#string

Howard D Weiss

http://www.w3.org/2001/XMLSchema#string

James R Williams

http://www.w3.org/2001/XMLSchema#string

John T Little

http://www.w3.org/2001/XMLSchema#string

Karen E Anderson

http://www.w3.org/2001/XMLSchema#string

Laura Marsh

http://www.w3.org/2001/XMLSchema#string

Peter V Rabins

http://www.w3.org/2001/XMLSchema#string

Russell L Margolis

http://www.w3.org/2001/XMLSchema#string

P2860

Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication

Excessive Daytime Sleepiness and Sudden-Onset Sleep in Parkinson Disease

Parkinson's disease: a preliminary study of yohimbine challenge in patients with anxiety

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

Stages in the development of Parkinson's disease-related pathology

Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data.

The noradrenergic system in pathological anxiety: a focus on panic with relevance to generalized anxiety and phobias.

The role of the locus coeruleus in the development of Parkinson's disease.

Frequency of social phobia and psychometric properties of the Liebowitz social anxiety scale in Parkinson's disease.

A review and meta-analysis of the genetic epidemiology of anxiety disorders.

P304

1333-1338

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MDS.22611

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P577

2009-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24410978

http://www.w3.org/2001/XMLSchema#string

P698

19425086

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

2830642

http://www.w3.org/2001/XMLSchema#string